Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 05'th Jun 2024
WESTLAKE VILLAGE, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
APX Acquisition Corp. I Reports 10-K Delinquency Notice
01:33pm, Wednesday, 05'th Jun 2024
NASHVILLE, Tenn. , June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI ) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficie
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?
09:45am, Wednesday, 05'th Jun 2024
Walgreens has lost some 70% of its value, and the stock now yields 6.5%. Kraft Heinz has experienced a similar slump, and its shares offer a 4.6% yield.
Nasdaq Grants Extension to Knightscope Until October 4, 2024
09:35am, Wednesday, 05'th Jun 2024
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $KSCP #SecurityRobot--Nasdaq Grants Extension to Knightscope.
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Wednesday, 05'th Jun 2024
RESEARCH TRIANGLE PARK, N.C., June 05, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, today announced the grant of inducement stock options exerci
3 Stocks Billionaires Are Buying in the Wake of the Nasdaq Bull Market
05:54am, Wednesday, 05'th Jun 2024
The Nasdaq has surged 60% off previous lows, but these skilled investors see opportunistic values in the market. Billionaires Daniel Loeb, Chase Coleman, and David Tepper see more upside in shares of
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Tuesday, 04'th Jun 2024
BOSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for
Vision Sensing Acquisition Corp. Announces Deficiency Notice from Nasdaq for Failure to Timely File 1st Quarter 2024 Form 10-Q and Announces Filing of 10-Q
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 04'th Jun 2024
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, ph
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:28pm, Tuesday, 04'th Jun 2024
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, d
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
04:20pm, Tuesday, 04'th Jun 2024
HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering priced at-the-market under
HeartSciences Regains Compliance with Nasdaq Listing Requirements
04:15pm, Tuesday, 04'th Jun 2024
Southlake, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-pow
MultiSensor AI Announces Compliance With Nasdaq Continued Listing Criteria
04:15pm, Tuesday, 04'th Jun 2024
HOUSTON, TX / ACCESSWIRE / June 4, 2024 / MultiSensor AI Holdings, Inc. (Nasdaq:MSAI, MSAIW), a pioneer in AI-powered industrial condition-based maintenance and process control solutions, today announ
Graphjet Technology Receives Notification of Delinquency from Nasdaq
04:15pm, Tuesday, 04'th Jun 2024
Kuala Lumpur, June 04, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology, a Cayman Islands exempt company (“Graphjet” or the “Company”) (Nasdaq: GTI), today announced that on May 30, 2024, the Comp
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Tuesday, 04'th Jun 2024
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, granted stock optio
